A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05686239 |
|
Recruitment Status :
Recruiting
First Posted : January 17, 2023
Last Update Posted : August 25, 2023
|
Sponsor:
Recognify Life Sciences
Information provided by (Responsible Party):
Recognify Life Sciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 15, 2024 |
| Estimated Study Completion Date : | November 15, 2024 |